PharmaShots | Incisive News in 3 Shots

Subscribe Now

timrepigene emparvovec

Biogen's BIIB111 Fails to Meet its Primary Endpoint in P-III STAR Study for Choroideremia

Biogen's BIIB111 Fails to Meet its Primary Endpoint in P-III STAR Study for Choroideremia

June 15, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us